CARL ZEISS MEDITEC ADR 1 (AFXA) — Free Cash Flow Generation Index
CARL ZEISS MEDITEC ADR 1 (AFXA) has a Free Cash Flow Generation Index of 0.47x as of September 2025. Free cash flow of €67.56 Million represents 0% of operating cash flow (€144.16 Million). Explore how much does CARL ZEISS MEDITEC ADR 1 reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
CARL ZEISS MEDITEC ADR 1 Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for CARL ZEISS MEDITEC ADR 1 across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does CARL ZEISS MEDITEC ADR 1 generate cash.
Annual Free Cash Flow Generation for CARL ZEISS MEDITEC ADR 1 (2022–2025)
Year-by-year Free Cash Flow Generation Index for CARL ZEISS MEDITEC ADR 1. Check CARL ZEISS MEDITEC ADR 1 (AFXA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | €133.26 Million | €209.86 Million | €76.59 Million | ▲ +65.1% |
| 2024 | 0.38x | €95.11 Million | €247.32 Million | €152.20 Million | ▼ -29.6% |
| 2023 | 0.55x | €137.00 Million | €250.86 Million | €113.86 Million | ▼ -3.2% |
| 2022 | 0.56x | €106.23 Million | €188.20 Million | €81.97 Million | — |